Clomiphene PCD Pharma Franchise Company
Cafoli Lifecare offers a Clomiphene range of 10 formulations in tablets and capsules, manufactured in WHO-GMP certified facilities. Distributors building a gynaecology and fertility portfolio can secure district-wise monopoly franchise rights on this first-line ovulation inducer.
What is Clomiphene?
Clomiphene citrate is a selective estrogen receptor modulator that blocks estrogen receptors in the hypothalamus, increasing gonadotropin release to stimulate ovulation. It is a first-line treatment for anovulatory infertility. Compound details are available on PubChem.
Therapeutic Applications
Clomiphene is used for ovulation induction in women with anovulatory infertility, including polycystic ovary syndrome, and in certain assisted-reproduction protocols. Prescribers are gynaecologists and infertility specialists.
Why Clomiphene is a High-Potential Molecule for Distributors
PCOS and infertility are increasingly diagnosed across urban and semi-urban India, and clomiphene remains the affordable first-line ovulation inducer that gynaecologists reach for before costlier options. Its prescription-bound, specialist-driven demand and cycle-based repeat dosing create a loyal, low-competition niche for franchise partners focused on womens health.
Why Choose Cafoli Lifecare
Cafoli Lifecare is a WHO-GMP compliant, DCGI-approved PCD pharma company with 1000+ franchise partners across India. Partners receive district-wise monopoly rights, promotional inputs including visual aids, MR bags and product cards, and consistent stock availability backed by quality-tested manufacturing.
References
- PubChem: Clomiphene
- MedlinePlus: Clomiphene
Our formulations of Clomiphene find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: